Exagen, Inc. (XGN)
7.65
-0.27
(-3.41%)
USD |
NASDAQ |
Aug 24, 16:00
7.61
-0.04
(-0.52%)
After-Hours: 20:00
Exagen Enterprise Value : 188.15M for Aug. 24, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 188.15M |
| August 21, 2026 | 194.68M |
| August 20, 2026 | 191.29M |
| August 19, 2026 | 182.82M |
| August 18, 2026 | 162.50M |
| August 17, 2026 | 165.16M |
| August 14, 2026 | 164.19M |
| August 13, 2026 | 162.26M |
| August 12, 2026 | 162.50M |
| August 11, 2026 | 166.86M |
| August 10, 2026 | 163.71M |
| August 07, 2026 | 169.27M |
| August 06, 2026 | 162.50M |
| August 05, 2026 | 163.95M |
| August 04, 2026 | 159.11M |
| August 03, 2026 | 116.29M |
| July 31, 2026 | 112.66M |
| July 30, 2026 | 116.05M |
| July 29, 2026 | 108.31M |
| July 28, 2026 | 110.73M |
| July 27, 2026 | 109.52M |
| July 24, 2026 | 116.29M |
| July 23, 2026 | 122.82M |
| July 22, 2026 | 122.58M |
| July 21, 2026 | 120.65M |
| Date | Value |
|---|---|
| July 20, 2026 | 116.29M |
| July 17, 2026 | 109.28M |
| July 16, 2026 | 105.89M |
| July 15, 2026 | 107.10M |
| July 14, 2026 | 102.02M |
| July 13, 2026 | 103.23M |
| July 10, 2026 | 110.73M |
| July 09, 2026 | 114.84M |
| July 08, 2026 | 108.55M |
| July 07, 2026 | 119.19M |
| July 06, 2026 | 109.52M |
| July 02, 2026 | 112.90M |
| July 01, 2026 | 117.02M |
| June 30, 2026 | 115.57M |
| June 29, 2026 | 120.05M |
| June 26, 2026 | 115.96M |
| June 25, 2026 | 117.40M |
| June 24, 2026 | 114.51M |
| June 23, 2026 | 110.54M |
| June 22, 2026 | 112.10M |
| June 18, 2026 | 114.99M |
| June 17, 2026 | 108.01M |
| June 16, 2026 | 115.23M |
| June 15, 2026 | 115.72M |
| June 12, 2026 | 118.12M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Myriad Genetics, Inc. | 386.88M |
| BioRestorative Therapies, Inc. | 1.874M |
| CareDx, Inc. | 2.091B |
| Natera, Inc. | 46.21B |
| Sera Prognostics, Inc. | 42.53M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -3.196M |
| Revenue (Quarterly) | 19.94M |
| Total Expenses (Quarterly) | 23.14M |
| EPS Diluted (Quarterly) | -0.1323 |
| Gross Profit Margin (Quarterly) | 61.27% |
| Profit Margin (Quarterly) | -16.03% |
| Earnings Yield | -10.53% |
| Normalized Earnings Yield | -9.997 |